Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials

Galling, B; Roldán, A; Rietschel, L; Hagi, K; Walyzada, F; Zheng, W; Cao, XL; Xiang, YT; Kane, JM; Correll, CU (2016). Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials. Expert Opinion on Drug Safety, 15(5), pp. 591-612. Taylor & Francis 10.1517/14740338.2016.1165668

Full text not available from this repository. (Request a copy)

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > University Psychiatric Services > University Hospital of Child and Adolescent Psychiatry and Psychotherapy
04 Faculty of Medicine > University Psychiatric Services > University Hospital of Child and Adolescent Psychiatry and Psychotherapy > Research Division

UniBE Contributor:

Rietschel, Liz

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1474-0338

Publisher:

Taylor & Francis

Language:

English

Submitter:

Fabienne Bolliger

Date Deposited:

11 Aug 2016 15:27

Last Modified:

09 Feb 2017 10:46

Publisher DOI:

10.1517/14740338.2016.1165668

PubMed ID:

26967126

URI:

https://boris.unibe.ch/id/eprint/85824

Actions (login required)

Edit item Edit item
Provide Feedback